Neurocompute Narrative Velocity Map
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative
Velocity Map

Explore the Parkinson’s research intelligence diagram before entering the Neurocompute platform.

NC
Neurocompute
AI Parkinson’s Intelligence Terminal
NARRATIVE VELOCITY ENGINE

Neurocompute

AI-driven Parkinson’s research intelligence platform exploring emerging signals, forgotten papers, and therapeutic patterns across the biomedical literature universe.

Indexed Papers
1,516
AI Scored
984
Ranked Papers
998
Coverage
1.3%
RESEARCH INTELLIGENCE BOARD

Ranked Parkinson’s Papers

1516 results
LAST INGEST 2026-05-29 06:45 PM
D
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications.
PMID 42022556 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Frontiers in pharmacology
AI 68.0
Base 49.2
Rank 46.3
AI Summary

In a 2-year longitudinal study of 28 levodopa‑naïve Parkinson's patients, women had significantly higher levodopa AUC and Cmax than men, and in women (but not men) higher exposure correlated with greater wearing‑off and dyskinesia.

Why It Matters

Provides clinically actionable evidence that sex-specific levodopa pharmacokinetics predispose women to motor complications, supporting early plasma monitoring and sex‑adjusted dosing to reduce levodopa-related adverse effects and personalize therapy.

D
Directional functional influence of the locus coeruleus on the whole brain in tremor-dominant and akinetic-rigid Parkinson's disease.
PMID 41921429 Published: 2026-03-29 Ingested: 2026-04-28 08:58 PM Parkinsonism & related disorders
AI 65.0
Base 49.2
Rank 46.3
AI Summary

This human neuroimaging study reports reduced locus coeruleus neuromelanin signal in PD and subtype-specific directional effective connectivity patterns between the LC, cerebellum, and cortical regions that correlate with motor severity in tremor-dominant versus akinetic-rigid patients.

Why It Matters

It identifies a noninvasive LC biomarker and subtype-specific functional signatures that could inform patient stratification and development of noradrenergic-targeted or personalized neuromodulation therapies in Parkinson's disease.

D
From General-Purpose to Disease-Specific Features: Aligning LLM Embeddings on a Disease-Specific Biomedical Knowledge Graph for Drug Repurposing.
PMID 41959530 Published: 2026-03-10 Ingested: 2026-04-28 08:58 PM bioRxiv : the preprint server for biology
AI 65.0
Base 49.2
Rank 46.3
AI Summary

Introduces CLEAR, a method that aligns LLM embeddings with a disease-specific knowledge graph to improve computational drug-repurposing predictions for ADRD, including Parkinson disease–related dementia, reporting up to 30% performance gains.

Why It Matters

Offers a scalable, context-grounded computational approach to prioritize FDA-approved repurposing candidates for Parkinson-related dementia and other ADRD in data-sparse settings, potentially accelerating translational follow-up despite lacking in vitro/in vivo validation.

AI Summary

In a randomized trial of 105 Parkinson's patients with constipation, adjunct Bifidobacterium animalis subsp. lactis combined with Liuwei'anxiao Capsule improved bowel movement frequency, stool form, patient-reported constipation scores and achieved a higher overall response rate versus either…

Why It Matters

This study offers a clinically actionable, microbiome-modulating adjunct therapy for a common and quality-of-life–limiting PD nonmotor symptom, supporting the gut–brain axis as a translational target and motivating follow-up trials to assess effects on broader PD outcomes or disease progression.

D
AI 64.0
Base 49.2
Rank 46.3
AI Summary

In a double-blind, sham-controlled RCT of 60 Parkinson's patients (H&Y 1–3), twice-daily high-intensity tACS added to multidisciplinary intensive rehabilitation produced significantly greater and durable improvements in PDQ-39 quality-of-life scores and reductions in depression and apathy up to 24…

Why It Matters

This trial delivers clinically actionable evidence that noninvasive high-intensity tACS can be a scalable, low-risk adjunct to rehabilitation to improve long-term QoL and non-motor symptoms in PD, making it a promising candidate for translation and for follow-up mechanistic and biomarker-driven…

D
AI 62.0
Base 49.2
Rank 46.3
AI Summary

In alpha‑synuclein–overexpressing SH‑SY5Y cells, incense aerosol extracts—particularly the organic phase—induce ROS‑linked mitochondrial dysfunction, programmed cell death, and a shift of alpha‑synuclein from oligomers to monomers, with limited rescue by classical antioxidants compared with…

Why It Matters

Points to incense smoke as a distinct environmental driver of alpha‑synuclein mis‑homeostasis and mitochondrial injury, offering mechanistic targets and the rationale that PD interventions may need to address non‑canonical toxicants/mechanisms beyond general antioxidant strategies.

D
AI 62.0
Base 49.2
Rank 46.3
AI Summary

This review highlights MRI-guided high-intensity focused ultrasound (MRgHIFU) as a noninvasive, tract-based neuromodulation approach using patient-specific diffusion MRI and advanced sequences to directly target pathological white-matter tracts (e.g., dentatorubrothalamic in ET, pallidothalamic in…

Why It Matters

Provides a clinically actionable, translational pathway for personalized, incisionless treatment of PD motor circuits that could expand therapeutic options and target selection (including AI-assisted planning), though it does not address molecular disease-modifying mechanisms.

D
Intermittent theta-burst stimulation to enhance physical therapy in Parkinson's disease: The STEP-PD randomized trial.
PMID 41926908 Published: 2026-04-01 Ingested: 2026-04-28 08:58 PM Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
AI 62.0
Base 49.2
Rank 46.3
AI Summary

In a double-blind randomized trial (STEP-PD), adding bilateral M1 intermittent theta-burst stimulation to a two-week intensive physical therapy program produced a modest but statistically significant acute improvement in OFF-state MDS-UPDRS III (Δ = -4.60, p = 0.034) with exploratory gains in gait…

Why It Matters

Provides a readily translatable, nonpharmacologic cortical-priming approach with objective EEG biomarkers that can enhance short-term rehabilitation outcomes in PD and serve as a platform for optimizing neuromodulation parameters and studying sustained clinical effects.

D
Small Molecule Inhibitors Targeting Pathogenic Protein Aggregation in Neurodegenerative Diseases: Medicinal Chemistry and Mechanistic Insights.
PMID 41926304 Published: 2026-04-01 Ingested: 2026-04-28 08:58 PM Current topics in medicinal chemistry
AI 62.0
Base 49.2
Rank 46.3
AI Summary

Comprehensive review of natural and synthetic small molecules—including polyphenols, quinones, alkaloids, metal chelators, osmolytes, and repurposed drugs—that inhibit misfolding and aggregation of amyloid-β, tau, and α-synuclein, with medicinal chemistry and mechanistic discussion.

Why It Matters

Valuable for Parkinson's therapeutic discovery because it compiles α‑synuclein‑targeting chemotypes and repurposing candidates and outlines mechanisms useful for hit selection and lead optimization, though it lacks deep clinical/translational validation.

D
AI 60.0
Base 49.2
Rank 46.3
AI Summary

A nationwide retrospective cohort study found acetylcholinesterase inhibitor (AChEI) use in Parkinson's disease dementia was associated with a 24% reduction in mortality, with larger benefits in females and in late-onset PD and no significant difference between donepezil and rivastigmine.

Why It Matters

Provides strong clinical evidence for potential repurposing of AChEIs to improve survival in PDD and highlights sex- and age-dependent effects that warrant mechanistic and trial-focused follow-up.

D
TCMNet: an AI-driven strategy for optimizing traditional Chinese medicine.
PMID 41918015 Published: 2026-03-31 Ingested: 2026-04-28 08:58 PM Chinese medicine
AI 60.0
Base 49.2
Rank 46.3
AI Summary

TCMNet is a computational pipeline that combines LLM-guided literature mining, weighted PPI network analysis, and deep-learning binding predictions to prioritize TCM formulas and constituent compounds for Parkinson's disease, highlighting Tianma Gouteng Decoction, enhanced synergy with levodopa,…

Why It Matters

This work offers a pragmatic, scalable triage tool to nominate herb-derived compounds, prioritized targets, and formula–drug combinations for experimental validation, accelerating translational follow-up in Parkinson's therapeutic discovery despite lacking wet-lab validation.

D
Effects of a Soft Robotic Exoskeleton for Gait Training on Clinical Outcomes in Patients With Parkinson Disease: Randomized Controlled Pilot Study.
PMID 42048524 Published: 2026-04-28 Ingested: 2026-04-28 08:58 PM Journal of medical Internet research
AI 52.0
Base 49.2
Rank 46.3
AI Summary

This randomized controlled pilot study found that adding 4 weeks of soft exoskeleton robot (SER) gait training to conventional rehabilitation significantly improved gait speed, stride length, ankle dorsiflexion, balance, and several clinical scales in people with Parkinson disease compared with…

Why It Matters

The work provides credible, quantitative evidence that a nonpharmacologic SER intervention can produce meaningful functional gains and links improved ankle mobility to better gait—valuable for rehabilitation practice and for selecting sensitive clinical outcome measures—though it offers little…

D
High-definition transcranial direct current stimulation for depressive and other non-motor symptoms in Parkinson's disease: a randomised, sham-controlled, cross-over study.
PMID 41916935 Published: 2026-03-01 Ingested: 2026-04-28 08:58 PM East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan
AI 52.0
Base 49.2
Rank 46.3
AI Summary

In a small randomized, sham-controlled crossover trial of 25 mild-to-moderate PD patients, two brief sessions of left DLPFC HD-tDCS improved depressive, cognitive, and other non-motor symptom scores versus sham with good tolerability.

Why It Matters

This study supports a safe, non-pharmacologic, symptomatic intervention for PD non-motor symptoms with translational potential for clinical management and trial design, but its small size and lack of mechanistic insight limit its value for disease-modifying therapeutic discovery.

D
AI 48.5
Base 49.2
Rank 46.3
AI Summary

Recently abstinent methamphetamine users showed Trail Making Test deficits consistent with Parkinsonian cognitive inflexibility, with intravenous use in women linked to greater errors.

Why It Matters

The work highlights a clinically relevant PD-like phenotype in methamphetamine users that could inform risk stratification and tailored interventions, but offers limited mechanistic or biomarker insight for direct therapeutic discovery.

D
AI 45.0
Base 49.2
Rank 46.3
AI Summary

This position-statement review finds MRgFUS thalamotomy is a safe and effective, durable option for refractory essential tremor and yields significant short-term benefit for Parkinsonian tremor, though long-term durability and some adverse effects remain concerns.

Why It Matters

Clinically important as a non‑pharmacologic, translational symptomatic therapy that informs patient management and trial design, but of limited direct value for molecular Parkinson's therapeutic discovery or disease‑modifying strategies.

D
Network-based Transcriptomic Profiling of Fetal Astrocyte Differentiation Reveals Therapeutic Targets for Neurodegenerative Disease.
PMID 41935371 Published: 2026-04-03 Ingested: 2026-04-28 08:58 PM Current molecular medicine
AI 40.0
Base 49.2
Rank 46.3
AI Summary

This computational study compared fetal astrocytes to neural stem cells, identifying 359 DEGs and ten ECM/adhesion-related hub genes (e.g., COL1A1, LOX, CD44, TIMP1) with drug-gene links to compounds such as estradiol, retinoic acid, and calcitriol.

Why It Matters

Although not PD-specific, the paper highlights astrocyte-expressed extracellular matrix and adhesion targets that could be pharmacologically modulated or repurposed as starting points for astrocyte-centered neuroprotective strategies relevant to Parkinson's disease.

D
The mechanism of external cueing interventions in improving freezing of gait in Parkinson's disease: an fNIRS study.
PMID 41938069 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Frontiers in aging neuroscience
AI 40.0
Base 49.2
Rank 46.3
AI Summary

Using fNIRS in 28 PD-FOG patients and 28 controls, the study shows rhythmic visual or auditory cues (but not their combination) acutely improve gait, increase oxyhemoglobin in PFC and S1, and strengthen functional connectivity among PFC, S1, M1, PMC and temporal/visual areas.

Why It Matters

Findings clarify cortical hemodynamic and connectivity mechanisms by which external cueing alleviates freezing of gait, supporting non-pharmacological therapies and potential cortical targets/biomarkers for neuromodulation, but provide limited direct molecular targets for drug discovery.

D
Sedentary behavior modifies the effect of balance rehabilitation on balance discordance in Parkinson's disease.
PMID 41991542 Published: 2026-04-16 Ingested: 2026-04-28 08:58 PM NPJ Parkinson's disease
AI 38.0
Base 49.2
Rank 46.3
AI Summary

Secondary analysis of two HiBalance trials (n=97) showed that overall balance training did not significantly change balance discordance in PD, but baseline sedentary behavior significantly modified post-intervention discordance in the clinical cohort.

Why It Matters

Although not addressing molecular targets, the result is clinically relevant for tailoring and stratifying rehabilitation interventions (and related trials) by sedentary behavior to better address perceived-versus-actual balance and potentially reduce fall risk.

D
AI 38.0
Base 49.2
Rank 46.3
AI Summary

Italian national survey of 424 adults with motor, sensory, or cognitive disabilities (including Parkinson's) identifying rehabilitation priorities, limited access to robotic interventions (39% had used them), higher satisfaction with technology-based rehab—especially for mobility—and strong demand…

Why It Matters

Offers patient-centered evidence to inform pragmatic clinical trial design, outcome selection, and deployment strategies for robotic/home-based rehabilitation in Parkinson's care, but contains no mechanistic or direct therapeutic discovery insights.

D
Exploiting the Danio rerio model and bioinformatics to explore the effects and molecular networks of Parkinson's disease drugs in human melanoma.
PMID 42025245 Published: 2026-04-17 Ingested: 2026-04-28 08:58 PM European journal of cell biology
AI 35.0
Base 49.2
Rank 46.3
AI Summary

Using zebrafish melanoma xenografts and bioinformatics, the authors evaluated Parkinson's drugs amantadine, rasagiline, and carbidopa, reporting LC50 values, limited anti‑melanoma efficacy (only dose‑dependent effects for amantadine), and molecular associations between PD and melanoma.

Why It Matters

While it offers limited direct insight into PD neuroprotective mechanisms, the paper provides in vivo safety/toxicity data, a zebrafish platform for repurposing screens, and bioinformatic links that could inform comorbidity studies or hypotheses for future repurposing efforts.

D
AI 34.0
Base 49.2
Rank 46.3
AI Summary

A UK cross-sectional survey of 102 PD patients on opicapone or entacapone found that increased ON time and reduced OFF time were the most valued benefits, that hallucinations and dyskinesia were the least acceptable side effects, and that clinician communication and follow-up around COMT inhibitor…

Why It Matters

Although not mechanistic, these real-world patient-reported findings are useful for informing clinical prescribing, shared decision-making, prioritizing outcomes for trials of motor-fluctuation therapies, and improving implementation of adjunctive COMT inhibitor treatment.

D
Appropriate use recommendations for digital technology in cognitive telerehabilitation for people living with Parkinson's disease.
PMID 41987502 Published: 2026-04-15 Ingested: 2026-04-28 08:58 PM Disability and rehabilitation. Assistive technology
AI 30.0
Base 49.2
Rank 46.3
AI Summary

This paper presents 16 consensus-based appropriate use recommendations for digital technology in cognitive telerehabilitation for people with Parkinson's disease, developed via SWOT analysis, workshops, and expert survey to address usability, safety, efficacy, and implementation.

Why It Matters

Although it provides little mechanistic or therapeutic discovery content, these practical guidelines can enhance implementation, patient access, and the design of remote cognitive intervention trials in PD, aiding clinical delivery and translational research readiness.

D
AI 25.0
Base 49.2
Rank 46.3
AI Summary

A 12-week single-group pilot found Cha-Cha dance training improved balance and cognitive test scores in mild–moderate Parkinson’s patients but lacked a control group.

Why It Matters

Findings support a feasible, safe non-pharmacological intervention that may reduce fall risk and boost cognition—valuable for symptomatic management and justifying controlled trials, but of limited direct relevance to molecular therapeutic discovery.

D
Mental health support and psychotherapy in Parkinson's: from misalignments to meaningful interactions.
PMID 42003558 Published: 2026-04-20 Ingested: 2026-04-28 08:58 PM Aging & mental health
AI 22.0
Base 49.2
Rank 46.3
AI Summary

Qualitative study of 28 people with Parkinson's characterizing barriers, shortcomings, helpful elements, and outcomes of professional psychological support and offering recommendations to optimize care.

Why It Matters

While not addressing molecular or disease-modifying targets, the findings are clinically relevant for improving mental health care delivery, quality of life, and potentially treatment adherence in Parkinson's patients, which can indirectly affect clinical outcomes.

D
Virtual reality as a therapeutic tool in modern healthcare.
PMID 41920719 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Casopis lekaru ceskych
AI 22.0
Base 49.2
Rank 46.3
AI Summary

This review describes virtual reality's growing use across medicine and notes some beneficial but methodologically limited evidence for motor rehabilitation and symptom management in Parkinson's disease.

Why It Matters

VR is valuable for symptomatic rehabilitation, objective outcome measurement, and potential digital biomarkers in PD trials, but it offers minimal actionable molecular or target-based insights for Parkinson's therapeutic discovery.

Previous
Page 14 of 61
Next
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic
Full Neurocompute Infographic